The road to implementation of pharmacokinetic-guided dosing of factor replacement therapy in hemophilia and allied bleeding disorders. Identifying knowledge gaps by mapping barriers and facilitators.

Goedhart, Tine M H J; Janssen, A; Mathôt, Ron A A; Cnossen, Marjon H

Goedhart, Tine M H J; Janssen, A; Mathôt, Ron A A; Cnossen, Marjon H.

Afiliação

Goedhart TMHJ; Department of Pediatric Hematology and Oncology, Erasmus MC Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands. Electronic address: m.c.h.j.goedhart@erasmusmc.nl.
Janssen A; Department of Clinical Pharmacology - Hospital Pharmacy, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: a.janssen@amsterdamumc.nl.
Mathôt RAA; Department of Clinical Pharmacology - Hospital Pharmacy, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: r.mathot@amsterdamumc.nl.
Cnossen MH; Department of Pediatric Hematology and Oncology, Erasmus MC Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands. Electronic address: m.cnossen@erasmusmc.nl.

Blood Rev ; 61: 101098, 2023 09.

Article em En | MEDLINE | ID: mdl-37321952

Assuntos

Hemofilia A; Humanos; Hemofilia A/complicações; Hemofilia A/tratamento farmacológico; Fator VIII/uso terapêutico

Palavras-chave

Factor IX; Factor VIII; Hemophilia A; Hemophilia B; Pharmacokinetics; Review

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemofilia A Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google